Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
about
L-asparaginase in the treatment of patients with acute lymphoblastic leukemiaAsparaginase pharmacokinetics and implications of therapeutic drug monitoringHow to manage asparaginase hypersensitivity in acute lymphoblastic leukemiaNon-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginaseThrombosis and acute lymphoblastic leukaemia.Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.Erwinia asparaginase in pediatric acute lymphoblastic leukemia.A critical review on properties and applications of microbial l-asparaginases.Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation.Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia.Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients.Measurement of subvisible particulates in lyophilised Erwinia chrysanthemi L-asparaginase and relationship with clinical experience.Discovery of human-like L-asparaginases with potential clinical use by directed evolution.Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia.Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.Pain intensity and bioavailability of intramuscular asparaginase and a local anesthetic: a double-blinded study.Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan.Proteins from Erwinia asparaginase Erwinase ® and E. coli asparaginase 2 MEDAC ® for treatment of human leukemia, show a multitude of modifications for which the consequences are completely unclear.
P2860
Q26738640-4CA8D10F-E8A4-46E2-9E93-78B25DE78C45Q27026476-6FBF80F5-CCAA-45B8-A804-69A2029B4D76Q27026952-23E4B957-FF88-410E-917D-B1C0AD08745CQ33557148-8E21C967-828F-4C27-9FF3-B5945E1EDC3AQ34400424-E43A914E-90C0-4F63-899B-F5FF982C9153Q36869374-2B7DF8ED-6620-4484-B0BC-E07776381F84Q36918761-7EA24339-D958-4886-9E61-B6E3CA550D4AQ36996143-E96120FE-6629-4B15-A7EB-E2F46EA96FDBQ37046992-0DD06ED3-DBA3-44E8-8203-ABCB08B720C2Q37563510-52424A72-047D-47F1-AF12-6E1E50B87C48Q37670065-5C057AFC-555E-43A0-8A92-46DC2069348EQ38040418-EF845CB7-F1AA-46D6-948E-DB8FB4879CC9Q38417141-45CBC4C6-9E4D-446A-A5D5-59899DF05E43Q38755617-621C2C3D-934E-4D8F-9FF5-945BBA1C31E3Q38880102-436D5163-5460-4895-A12A-4C9077C7669FQ38934988-5A00C781-E256-45F2-B45C-58ABE6048E0AQ41150769-56A9241F-29FB-4112-B8BA-8D3BEE3983B9Q41581505-DD5245AF-DE74-4270-8F0F-861859328BC3Q43025556-3B74947F-9B9A-45AC-AB09-AEA35A82B531Q48203946-D27E9FDD-6419-471B-AF4E-964B89F8A973Q48830656-45DA4FE1-A9F0-4AC6-BDCA-C877306837E2Q50868882-CDFB749D-5809-4762-9C86-E1E01F794239Q54356820-8042A81A-500A-43EB-ACDB-072169245E08
P2860
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Comparison of intramuscular th ...... nce on the coagulation system.
@en
Comparison of intramuscular th ...... nce on the coagulation system.
@nl
type
label
Comparison of intramuscular th ...... nce on the coagulation system.
@en
Comparison of intramuscular th ...... nce on the coagulation system.
@nl
prefLabel
Comparison of intramuscular th ...... nce on the coagulation system.
@en
Comparison of intramuscular th ...... nce on the coagulation system.
@nl
P2093
P2860
P1476
Comparison of intramuscular th ...... nce on the coagulation system.
@en
P2093
Albertsen BK
Avramis VI
Carlsen NT
Ingerslev J
Jakobsen P
Schmiegelow K
Schrøder H
P2860
P304
P356
10.1046/J.1365-2141.2001.03148.X
P407
P577
2001-12-01T00:00:00Z